Skip to the page

Data / Form D filings / Enduraphin, Inc.

Enduraphin, Inc.: Form D filing

Enduraphin, Inc., a manufacturing company in Binghamton, NY, filed a Form D with the SEC in 2018. The latest, on May 25, 2018, reports $100,000 sold of an offering with no set size to 6 investors.

Find out what Enduraphin, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
120 Hawley Street, Binghamton, NY, 13901
Phone
(315) 450-5009
Industry
Manufacturing
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1741981

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Manufacturing: 774 rows, $38.70, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 25, 2018New noticeIndefinite$100,000Indefinite6May 24, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Daniel M DrakeExecutive Officer, Director
Michael S DalberthExecutive Officer, Director

Other manufacturing companies in New York that filed recently

Every Form D from the week of May 21, 2018 · All recent filings in New York · All recent Manufacturing filings

Read from SEC EDGAR. Amount sold is what Enduraphin, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.